Jeffrey H. Newcorn, MD
Professor of Psychiatry and Pediatrics
Director, Division of ADHD and Learning Disorders
Icahn School of Medicine at Mount Sinai
Director, Pediatric Psychopharmacology
Mount Sinai Health System
Dr. Jeffrey Newcorn is Professor of Psychiatry and Pediatrics and Director of the Division of ADHD and Learning Disorders
at Icahn School of Medicine at Mount Sinai Medical Center in New York. He received his undergraduate and medical degrees from the University of Rochester. He completed his general psychiatry and child and adolescent psychiatry training at Tufts-New England Medical Center.
Dr. Newcorn is a highly-regarded researcher in the areas of Attention-Deficit/Hyperactivity Disorder (ADHD), aggression, descriptive psychopathology of child and adolescent disorders, and child and adolescent psychopharmacology. His work spans both clinical and translational topics. He is a member of the steering committee of the NIMH-funded multicenter study “Multimodal Treatment of Children with ADHD (MTA).” He was a member of the DSM-IV advisory committees on child and adolescent disorders and disruptive behavior disorders. He is the primary investigator on a NIMH-funded ADHD Research Infrastructure Network devoted to understanding the neurobiology of ADHD, and is the principle investigator or co-investigator on several NIMH-funded grants that examine the clinical, genetic, neuroanatomic and neurophysiologic basis of ADHD its treatment. He is a nationally recognized educator and mentor, and is the primary or secondary mentor on five NIMH training grants. He is an editorial board member of several leading child psychiatry and psychology journals, and conducts ad hoc reviews for many other leading psychiatry journals, and NIMH. Dr. Newcorn directs an active clinical trials program, and has studied many of the newer medication treatments for ADHD. He has published over 150 peer-reviewed articles and book chapters on these and related subjects.